Inhibiting host-pathogen interactions using membrane-based nanostructures

Trends in Biotechnology

Volumn 30, Issue 6, 2012, Pages 323-330

  Bricarello, Daniel A ^a   Patel, Mira A ^b   Parikh, Atul N ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California Davis   (United States)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Antipathogenic decoys; Antiviral; Binding affinity; Host pathogen interaction; Membrane nanostructures; Membrane receptors; Reconstituted (synthetic) lipoprotein

Indexed keywords

ANTIPATHOGENIC DECOYS; ANTIVIRAL; BINDING AFFINITIES; HOST-PATHOGEN INTERACTIONS; MEMBRANE RECEPTORS; RECONSTITUTED (SYNTHETIC) LIPOPROTEIN;

BACTERIA; BINDING ENERGY; CELL MEMBRANES; COMPUTER VIRUSES; LIPID BILAYERS; LIPOSOMES; MACHINERY; VIRUSES;

NANOSTRUCTURES;

ANTHRAX TOXIN; CARDIOLIPIN; CELL RECEPTOR; HEMAGGLUTININ; HIGH DENSITY LIPOPROTEIN; LIPOSOME; NANOMATERIAL; VIRULENCE FACTOR;

ADENOVIRUS; BACTERIAL VIRULENCE; CELL AGGREGATION; CELL FUNCTION; CONFORMATIONAL TRANSITION; ESCHERICHIA COLI; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFLUENZA VIRUS; LIPID BILAYER; NONHUMAN; PARAMYXOVIRUS; PATHOGENESIS; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; RHINOVIRUS; STAPHYLOCOCCUS; STREPTOCOCCUS; VIBRIO CHOLERAE;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; LIPID BILAYERS; LIPOSOMES; NANOSTRUCTURES; VIRUS DISEASES; VIRUSES;

EID: 84861341250     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.03.002     Document Type: Review

References (72)

1. Neu H. The crisis in antibiotic resistance. Science 1992, 257:1064-1073.
2. Morens D.M., et al. The challenge of emerging and re-emerging infectious diseases. Nature 2004, 430:242-249.
3. Potter C.W. A history of influenza. J. Appl. Microbiol. 2001, 91:572-579.
4. Moscona A. Medical management of influenza infection. Annu. Rev. Med. 2008, 59:397-413.
5. Ferguson N.M., et al. Strategies for mitigating an influenza pandemic. Nature 2006, 442:448-452.
6. Marsh M., Helenius A. Virus entry: open sesame. Cell 2006, 124:729-740.
7. Knodler L.A., et al. Pathogenic trickery: deception of host cell processes. Nat. Rev. Mol. Cell Biol. 2001, 2:578-588.
8. Bhavsar A.P., et al. Manipulation of host-cell pathways by bacterial pathogens. Nature 2007, 449:827-834.
9. Wang J.H. Protein recognition by cell surface receptors: physiological receptors versus virus interactions. Trends Biochem. Sci. 2002, 27:122-126.
10. Imberty A., Varrot A. Microbial recognition of human cell surface glycoconjugates. Curr. Opin. Struct. Biol. 2008, 18:567-576.
11. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
12. Tsai B., et al. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 2003, 22:4346-4355.
13. Varki N.M., Varki A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab. Invest. 2007, 87:851-857.
14. Pelkmans L., Helenius A. Endocytosis via caveolae. Traffic 2002, 3:311-320.
15. Mercer J., et al. Virus entry by endocytosis. Annu. Rev. Biochem. 2010, 79:803-833.
16. Kline K.A., et al. Bacterial adhesins in host-microbe interactions. Cell Host Microbe 2009, 5:580-592.
17. Cossart P., Sansonetti P.J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004, 304:242-248.
18. Pizarro-Cerd J., Cossart P. Bacterial adhesion and entry into host cells. Cell 2006, 124:715-727.
19. Ham H., et al. Manipulation of host membranes by bacterial effectors. Nat. Rev. Microbiol. 2011, 9:635-646.
20. Sixma T.K., et al. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 1991, 351:371-377.
21. Merritt E.A., Hol W.G.J. AB5 toxins. Curr. Opin. Struct. Biol. 1995, 5:165-171.
22. Fleckenstein J.M., et al. Molecular mechanisms of enterotoxigenic Escherichia coli infection. Microbes Infect. 2010, 12:89-98.
23. Ewers H., Helenius A. Lipid-mediated endocytosis. Cold Spring Harb. Perspect. Biol. 2011, 3:a004721.
24. Eckert D.M., Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 2001, 70:777-810.
25. Odegard A., et al. Flock house virus: a model system for understanding non-enveloped virus entry and membrane penetration. Cell Entry by Non-Enveloped Viruses 2010, 1-22. Springer-Verlag. J.E. Johnson (Ed.).
26. Lamb R.A., Jardetzky T.S. Structural basis of viral invasion: lessons from paramyxovirus F. Curr. Opin. Struct. Biol. 2007, 17:427-436.
27. Ofek I., et al. Anti adhesion therapy of bacterial diseases: prospects and problems. FEMS Immunol. Med. Microbiol. 2003, 38:181-191.
28. Rasko D.A., Sperandio V. Anti-virulence strategies to combat bacteria-mediated disease. Nat. Rev. Drug Discov. 2010, 9:117-128.
29. Scobie H.M., et al. A soluble receptor decoy protects rats against anthrax lethal toxin challenge. J. Infect. Dis. 2005, 192:1047-1051.
30. Newburg D.S. Neonatal protection by an innate immune system of human milk consisting of oligosaccharides and glycans. J. Anim. Sci. 2009, 87:26-34.
31. Newburg D.S., et al. Human milk glycans protect infants against enteric pathogens. Annu. Rev. Nutr. 2005, 25:37-58.
32. Lingwood D., Simons K. Lipid rafts as a membrane-organizing principle. Science 2010, 327:46-50.
33. Malmendier C., et al. In vivo metabolism of human apoprotein AI-phospholipid complexes. Comparison with human high density lipoprotein-apoprotein AI metabolism. Clin. Chim. Acta 1983, 131:201-210.
34. Sackmann E. Supported membranes: scientific and practical applications. Science 1996, 271:43.
35. Tanaka M., Sackmann E. Polymer-supported membranes as models of the cell surface. Nature 2005, 437:656-663.
36. Bricarello D.A., et al. Ganglioside embedded in reconstituted lipoprotein binds cholera toxin with elevated affinity. J. Lipid Res. 2010, 51:2731-2738.
37. Jung H., et al. Multivalent ligand-receptor binding on supported lipid bilayers. J. Struct. Biol. 2009, 168:90-94.
38. Bashat S., et al. Polyvalent inhibitors of anthrax toxin that target host receptors. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:13509-13513.
39. Young J.A.T., Collier R.J. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu. Rev. Biochem. 2007, 76:243-265.
40. Rai P., et al. Stable and potent polyvalent anthrax toxin inhibitors: raft-inspired domain formation in liposomes that contain PEGylated lipids. Chem. Eur. J. 2008, 14:7748-7751.
41. Malavia N.K., et al. Liposomes for HIV prophylaxis. Biomaterials 2011, 32:8663-8668.
42. Konopka K., et al. Liposomes modulate human-immunodeficiency-virus infectivity. J. Gen. Virol. 1990, 71:2899-2907.
43. Dhal P.K., et al. Functional polymers as therapeutic agents: concept to market place. Adv. Drug Deliv. Rev. 2009, 61:1121-1130.
44. Ashley C.E., et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 2011, 10:389-397.
45. Liu J.W., et al. Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles. J. Am. Chem. Soc. 2009, 131:1354-1355.
46. Carmona-Ribeiro A.M. Biomimetic particles in drug and vaccine delivery. J. Liposome Res. 2007, 17:165-172.
47. Buranda T., et al. Biomimetic molecular assemblies on glass and mesoporous silica microbeads for biotechnology. Langmuir 2003, 19:1654-1663.
48. Porotto M., et al. Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus. PLoS ONE 2011, 6:e16874.
49. Porotto M., et al. Viral entry inhibitors targeted to the membrane site of action. J. Virol. 2010, 84:6760-6768.
50. Farzan S., et al. Premature activation of the paramyxovirus fusion protein before target cell attachment: corruption of the viral fusion machinery. J. Biol. Chem. 2011, 286:37945-37954.
51. Whorton M., et al. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7682-7687.
52. Bricarello D.A., et al. Reconstituted lipoprotein: a versatile class of biologically-inspired nanostructures. ACS Nano 2011, 5:42-57.
53. Bayburt T., et al. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J. Biol. Chem. 2007, 282:14875-14881.
54. Cappuccio J.A., et al. Cell-free co-expression of functional membrane proteins and apolipoprotein, forming soluble nanolipoprotein particles. Mol. Cell. Proteomics 2008, 7:2246-2253.
55. Bayburt T., et al. Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer. J. Struct. Biol. 1998, 123:37-44.
56. Baker S.E., et al. Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particles. J. Am. Chem. Soc. 2009, 131:7508-7509.
57. Bayburt T.H., Sligar S.G. Self-assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers. Protein Sci. 2003, 12:2476-2481.
58. 1 clustering inhibits cholera toxin binding in supported phospholipid membranes. J. Am. Chem. Soc. 2007, 129:5954-5961.
59. Lauer S., et al. Analysis of cholera toxin-ganglioside interactions by flow cytometry. Biochemistry 2002, 41:1742-1751.
60. Bhattacharya P., et al. Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection. J. Virol. 2010, 84:361-371.
61. Vinchurkar M.S., et al. Bridging across length scales: multi-scale ordering of supported lipid bilayers via lipoprotein self-assembly and surface patterning. J. Am. Chem. Soc. 2008, 130:11164-11169.
62. Bray D., et al. Receptor clustering as a cellular mechanism to control sensitivity. Nature 1998, 393:85-88.
63. Boldog T., et al. Nanodiscs separate chemoreceptor oligomeric states and reveal their signaling properties. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:11509-11514.
64. Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 1988, 13:443-447.
65. Van Meer G., et al. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 2008, 9:112-124.
66. Spangler B.D. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Mol. Biol. Rev. 1992, 56:622-647.
67. Bhakdi S., et al. Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch. Microbiol. 1996, 165:73-79.
68. Takeda M., et al. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:14610-14617.
69. Bhat S., et al. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:7131-7134.
70. Bonaparte M.I., et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10652-10657.
71. Staunton D.E., et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989, 56:849-853.
72. Bergelson J.M., et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.